1792 Insights
The 1792 Exchange is committed to delivering sharp, data-driven analysis of corporate America’s political entanglements. Discover what investors, executives, and concerned citizens should know regarding why businesses should return to neutral, mission-focused operations.
New Heritage Report Highlights Risks of Corporate Alignment With the Human Rights Campaign
Last week, The Heritage Foundation released a very important report detailing the risks companies face from affiliating with the Human Rights Campaign (HRC) and its Corporate Equality Index (CEI). The report provides valuable insight into the scope of HRC’s influence on corporate America and the organizations pushing back against it. Any institution concerned about the growing influence of modern gender ideology should familiarize itself with these findings. In short, the CEI pressures companies to incorporate gender ideology into nearly every aspect of corporate governance, including employee healthcare benefits, charitable giving, and marketing. Its influence likely contributed to the controversial Bud Light and Target marketing decisions in 2023. Fortune 500 CEI participation dropped 65% this year, marking its first significant decline. However, according to Inspire Investing and the 1792 Exchange, there are still 242 publicly traded companies with a Verified 100 on the 2026 CEI, indicating coverage of transgender medical interventions for minors. Furthermore, 40 companies remain corporate partners of the HRC, including T-Mobile. This raises questions about T-Mobile’s pledge last year to the Federal Communications Commission that its approach to external organizations is “driven by [its] desire to advance [its] core business objectives.” Another corporate partner is Dell Technologies, which …
Corporate America’s Gender Ideology Ally Has A 99% Democratic Endorsement Record
As Americans prepare to vote in November’s midterm elections, one of the Democratic Party’s most reliable political allies is mobilizing millions of voters and spending millions of dollars to influence the results. That organization is the Human Rights Campaign (HRC), which also happens to maintain close ties with some of America’s largest corporations, many of which publicly affiliate with and sponsor the organization. HRC bills itself as the nation’s largest advocacy organization dedicated to advancing LGBTQ equality. But a new analysis by 1792 Exchange reveals just how overwhelmingly partisan its political activities have become. After examining HRC’s online archive of press releases, 1792 Exchange documented 1,408 political endorsements covering 970 unique candidates between 2010 and October 2026. Of those 970 candidates, 964 were Democrats, two were Republicans, three were nonpartisan candidates and one was an independent. In other words, more than 99% of the unique candidates identified in HRC’s archived endorsements were Democrats. This record raises questions for companies that financially support HRC or affiliate with its infamous Corporate Equality Index under the banner of supporting nondiscrimination policies, particularly when they do not extend comparable affiliation with or support of conservative organizations. And HRC’s political operation is not slowing down …
Corporate stewardship, the cost of ideological activism, and the trust that built America.
In this episode of The WallBuilders Show, Doug Napier, Executive Chairman and CEO of 1792 Exchange, joined host Rick Green to discuss The American Company, 1792 Exchange’s new effort to define and celebrate companies that act American. The conversation explores what separates a patriotic company from one that only waves the flag, and how Americans can help recognize the companies doing it right. Key Topics Discussed:
The Companies That Left HRC’s Index Are Still Sponsoring Gender Ideology
Several major corporations that publicly stepped back from DEI programs and the Human Rights Campaign’s Corporate Equality Index may not have retreated as far as headlines suggested. A new Blaze Media report, drawing on 1792 Exchange’s tracking, finds that Ford, Molson Coors, Target, and T-Mobile continued to bankroll LGBT activist events in 2026 even after signaling reform. The piece uses 1792 Exchange’s work on corporate DEI commitments, CEI participation, and ideological nonbusiness activities to show the gap between what these companies announced and what they still fund. Each of the four had signaled a change: Ford (2024) and Molson Coors (2024) said they would exit the CEI, and Target (2025) and T-Mobile (2025) announced they were ending DEI initiatives and index participation. Yet in 2026, Target was listed as a platinum sponsor of NYC Pride — whose youth programming included a rally “to demand protections for trans and queer youth” — along with Pride events in Los Angeles, Houston, San Francisco, Salt Lake City, and New Jersey. Molson Coors, through its Vizzy brand, sponsored Pride events in Miami Beach, Denver, and New Jersey; T-Mobile backed Pride events in Phoenix, Des Moines, and Philadelphia. Children appear to have been present at …
Inspire Investing Maps the Four-Year Reversal on Gender-Transition Care for Minors
On August 11, 2026, the Centers for Medicare & Medicaid Services issued a first-of-its-kind final rule barring federal Medicaid and CHIP dollars from covering puberty blockers, cross-sex hormones, or surgeries for minors, effective October 13, 2026. A new analysis from Inspire Investing frames the rule as the capstone of a four-year reversal across American law, medicine, and corporate benefit plans. The piece, by Chris Hubbard with Tim Schwarzenberger, traces how a once-expanding consensus fractured, in the courts, in the medical literature, in Europe, and in corporate boardrooms, and why values-driven investors are now pressing companies on the issue. The Supreme Court’s June 2025 ruling in United States v. Skrmetti upheld state limits, leaving bans in roughly 27 states in force. A May 2025 HHS evidence review found the certainty of benefit “very low,” echoing England’s Cass Review. Corporate participation in the Human Rights Campaign’s Corporate Equality Index fell 65% in a single year, from 377 Fortune 500 companies to 131. 1792 Exchange has named 550-plus companies whose plans still cover these procedures for minor dependents and wrote to 568 companies in June urging them to exclude transgender drugs and surgeries for children. Inspire organized a coalition representing more than $100 …
Mount Sinai Backs Down. Will Corporate America?
The writing is on the wall for gender ideology and corporate America should respond. Its authorities are discredited, its sciences unfounded, and its public support dwindling — not to mention the very providers who push sex-denying procedures on minors are now being held accountable for the experiment they’ve been running. Mount Sinai Health System is the latest example of this as they reach an agreement with the Department of Justice to stop providing sex-denying procedures on minors and provide free health care to those experiencing adverse side-effects of their experimentation. DOJ began its investigation on the premise that the nonprofit hospital may have violated federal law regarding its sex-denying procedures on children. The nationwide probe follows the landmark HHS report that exposed WPATH perverse influences on providers, along with an insurance scheme that let hospitals to charge insurance, private and federally subsidized, for sex-denying procedures on minors that would typically not be covered. Additionally, Mount Sinai agreed to dedicate $2 million to treating the adverse effects of sex-denying interventions, free of charge, to those who received them as minors. Keep in mind, sex-denying interventions are largely irreversible and carry side effects into adulthood, even for those who detransition. Detranstitioner Chloe …